Ryosuke Kuribayashi

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 10

Top Topics

Peritoneal Dialysis

Chronic Kidney Disease

Clinical Practice

Top Venues

Pharmaceutical medicine

European journal of drug metabolism and pharmacokinetics

Clinical pharmacokinetics

This page only lists publications with an associated author ORCID identifier.

Publications

Ryosuke Kuribayashi, Aya Hariu, Ayuki Nakano, Yasuhiro Kishioka
Survey of Data Package and Sample Size of Comparative Clinical Studies for Biosimilar Developments from PMDA Assessments. Pharmaceutical medicine 38 (3) (2024)
Ryosuke Kuribayashi, Aya Hariu, Ayuki Nakano, Yasuhiro Kishioka
Survey of Data Package and Sample Size of Comparative Clinical Studies for Biosimilar Developments from PMDA Assessments. Pharmaceutical medicine 38 (3) (2024)
Ryosuke Kuribayashi, Aya Hariu, Ayuki Nakano, Yasuhiro Kishioka
Survey of Data Package and Sample Size of Comparative Clinical Studies for Biosimilar Developments from PMDA Assessments. Pharmaceutical medicine (2024)
Ryosuke Kuribayashi, Ayuki Nakano, Aya Hariu, Yasuhiro Kishioka, Futaba Honda
Historical Overview of Regulatory Approvals and PMDA Assessments for Biosimilar Products in Japan During 2009-2022. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy (2023)
Ryosuke Kuribayashi, Miho Kasuga, Kimika Kuwana, Toru Yamaguchi
First Approval of Generic Mometasone Furoate Nasal Suspension Spray in Japan: Similarities and Differences Between Japan and the USA. Therapeutic innovation & regulatory science (2022)
Miho Kasuga, Ryosuke Kuribayashi, Takumi Ogawa, Akiko Ugi, Toru Yamaguchi, Kazunori Takagi, Mitsue Hirota
Generic Drug Product Development in Japan: Regulatory Updates During 2014-2019 and the Future. European journal of drug metabolism and pharmacokinetics 46 (6) (2021)
Ryosuke Kuribayashi, Toru Yamaguchi, Kazunori Takagi
Modernization and Strengthening of Bioequivalence Guidelines in Japan. Clinical pharmacokinetics 60 (2) (2020)
Ryosuke Kuribayashi, Aya Myoenzono, Kazunori Takagi, Mitsue Hirota
Current Understanding of the Equivalence Evaluations for In Vitro Tests on Generic Dry Powder Inhaler Drug Products in Japan. European journal of drug metabolism and pharmacokinetics 44 (6) (2020)
Ryosuke Kuribayashi, Scott Appleton
Comparison of Generic Drug Reviews for Marketing Authorization between Japan and Canada. Drugs in R&D 17 (3) (2018)
Ryosuke Kuribayashi, Toru Yamaguchi, Hanaka Sako, Tomoko Takishita, Kazunori Takagi
Bioequivalence Evaluations of Generic Dry Powder Inhaler Drug Products: Similarities and Differences Between Japan, USA, and the European Union. Clinical pharmacokinetics 56 (3) (2017)